Research Topics
| Lorrin M KoranSummaryAffiliation: Stanford University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuationLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA
J Clin Psychiatry 66:515-20. 2005..Mirtazapine enhances serotonergic function by a mechanism distinct from reuptake inhibition. Because a pilot study suggested effectiveness of mirtazapine in OCD, we conducted a controlled trial...
Medical disorders among patients admitted to a public-sector psychiatric inpatient unitLorrin M Koran
Department of Psychiatry and Behavioral Science, OCD Clinic, Stanford University Medical Center, Room 2363, 401 Quarry Road, Stanford, CA 94305, USA
Psychiatr Serv 53:1623-5. 2002..5 percent of the patients, respectively. Patients admitted to psychiatric inpatient units should be carefully evaluated for physical disease...
A 1-year naturalistic follow-up of patients with compulsive shopping disorderElias Aboujaoude
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, Calif, USA
J Clin Psychiatry 64:946-50. 2003..CONCLUSION: An acute response to citalopram predicts a greater likelihood of continued remission over 1 year, although the mechanisms that maintain remission require further investigation...
Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label studyAnn M Bogan
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
J Clin Psychiatry 66:73-9. 2005..The poorer results at S2 may reflect the large proportion of hoarders or the less intense treatment. Longer, higher dose, large, double-blind, placebo-controlled comparison trials of atypical antipsychotics are needed...
The prevalence of body dysmorphic disorder in the United States adult populationLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305, USA
CNS Spectr 13:316-22. 2008..Limited surveys report widely varying prevalence estimates. To better establish the prevalence of BDD, we conducted a United States nationwide prevalence survey...
Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorderLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
J Clin Psychiatry 66:353-9. 2005..A case series reported substantial response to once-weekly oral morphine. We conducted a placebo-controlled, double-blind trial to investigate whether once-weekly oral morphine is effective in SRI-resistant OCD...
Double-blind study of dextroamphetamine versus caffeine augmentation for treatment-resistant obsessive-compulsive disorderLorrin M Koran
OCD Clinic, Stanford, CA 94305, USA
J Clin Psychiatry 70:1530-5. 2009....
Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorderLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
J Clin Psychopharmacol 26:79-83. 2006..Small studies have suggested that intravenous clomipramine (CMI) may be more effective and induce faster improvement in obsessive-compulsive disorder than do orally administered serotonin reuptake inhibitors...
Estimated prevalence of compulsive buying behavior in the United StatesLorrin M Koran
OCD Clinic, Rm 2363, 401 Quarry Rd, Stanford, CA 94305, USA
Am J Psychiatry 163:1806-12. 2006..8% to 16% of the adult U.S. population. To the authors' knowledge, no study has used a large general population sample to estimate its prevalence...
Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patientsIra D Glick
Stanford University School of Medicine, Department of Psychiatry, 401 Quarry Rd, Suite 2122, Stanford, CA 94305, USA
J Clin Psychiatry 69:1856-9. 2008..This study examined aripiprazole treatment of patients with comorbid schizophrenia and obsessive-compulsive symptoms (OCS) that did not meet full criteria for OCD...
Escitalopram treatment of kleptomania: an open-label trial followed by double-blind discontinuationLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA, USA
J Clin Psychiatry 68:422-7. 2007..Kleptomania has no definitive treatment. Mixed reports of benefit from openly prescribed selective serotonin reuptake inhibitors led us to design a double-blind, placebo-controlled discontinuation trial of escitalopram...
Duloxetine treatment of dysthymia and double depression: an open-label trialLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, Calif, USA
J Clin Psychiatry 68:761-5. 2007..Antidepressants and some psychotherapies are often effective. We explored the efficacy of the antidepressant duloxetine, a serotonin and norepinephrine reuptake inhibitor...
Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorderLorrin M Koran
Department of Psychiatry, Stanford University, CA 94305, USA
Am J Psychiatry 159:88-95. 2002..Despite the need for long-term treatment, the authors found no placebo-controlled studies that have examined the relapse-prevention efficacy of maintenance therapy...
Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorderLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA 94305, USA
Compr Psychiatry 51:373-9. 2010..We also hypothesized that greater OCD symptom improvement in the first 12 weeks of treatment would be associated with greater HRQOL improvement after 52 weeks of treatment...
Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuationLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Calif, USA
J Clin Psychiatry 64:793-8. 2003..To test the hypothesis that citalopram is a safe, effective treatment for this disorder, we conducted a 7-week, open-label trial followed by a 9-week, double-blind, placebo-controlled discontinuation trial...
Citalopram treatment of compulsive shopping: an open-label studyLorrin M Koran
Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, Calif, USA
J Clin Psychiatry 63:704-8. 2002..Because an open-label trial suggested that fluovaxamine, a selective serotonin reuptake inhibitor (SSRI), is effective for this disorder, we tested the effectiveness of the SSRI citalopram...
Potential markers for problematic internet use: a telephone survey of 2,513 adultsElias Aboujaoude
Impulse Control Disorders Clinic, Department of Psychiatry and Behavioral Medicine, Stanford University School of Medicine, Palo Alto, CA 94305, USA
CNS Spectr 11:750-5. 2006..Future studies should delineate whether problematic Internet use constitutes a pathological behavior that meets criteria for an independent disorder, or represents a symptom of other psychopathologies...
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depressionMichael E Thase
Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, 3811 O Hara St, Pittsburgh, PA 15213, USA
Arch Gen Psychiatry 59:233-9. 2002..Although various strategies have been proposed to treat antidepressant nonresponders, little controlled research has been published that examines prospectively the use of switching to an alternate antidepressant...
Refractory obsessive-compulsive disorder: state-of-the-art treatmentEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 63:20-9. 2002..The authors synthesize state-of-the-art treatment and give practical advice for clinicians...
Practice guideline for the treatment of patients with obsessive-compulsive disorderLorrin M Koran
Am J Psychiatry 164:5-53. 2007
Escitalopram for compulsive buying disorder: a double-blind discontinuation studyLorrin M Koran
J Clin Psychopharmacol 27:225-7. 2007
Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trialStefano Pallanti
Istituto di Neuroscienze, and University of Florence, School of Medicine, Italy
J Clin Psychiatry 63:796-801. 2002..The selective serotonin reuptake inhibitor citalopram is effective for OCD when administered orally. We investigated whether intravenous citalopram would rapidly benefit OCD patients unresponsive to orally administered SRIs...
Venlafaxine in treatment-resistant obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:546-50. 2003..Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that might be effective in the treatment of OCD, even among those who have failed previous SSRI trials...
High-dose sertraline strategy for nonresponders to acute treatment for obsessive-compulsive disorder: a multicenter double-blind trialPhilip T Ninan
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, 1841 Clifton Road, Atlanta, GA 30329, USA
J Clin Psychiatry 67:15-22. 2006..To evaluate the efficacy and safety of high-dose sertraline for patients with obsessive-compulsive disorder (OCD) who failed to respond to standard sertraline acute treatment...
A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorderEric Hollander
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
J Clin Psychiatry 64:640-7. 2003....
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander
Mt Sinai School of Medicine, One Gustave Levy Place, Box 1230, NY, NY 10029, USA
J Neuropsychiatry Clin Neurosci 17:472-7. 2005..These subtle neurological abnormalities may implicate a potential subgroup of OCD patients with poorer treatment response. This may have treatment implications and therefore serve as a screening tool in OCD...
Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combinationJames H Kocsis
Department of Psychiatry, Weill Cornell Medical College, New York, NY 10021, USA
Psychopharmacol Bull 37:73-87. 2003..COMB was associated with less symptom re-emergence during the continuation phase than either monotherapy, particularly for partial remitters...
A case of kleptomania correlating with premenstrual dysphoriaElias Aboujaoude
J Clin Psychiatry 65:725-6. 2004
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combinationRobert M A Hirschfeld
Department of Psychiatry and Behavioral Sciences, University of Texas Medical Branch, Galveston, Texas 77555 0188, USA
Biol Psychiatry 51:123-33. 2002..This study compared efficacy of nefazodone, psychotherapy, and their combination in improving psychosocial functioning in chronically depressed outpatients...
Serotonin-1D hypothesis of obsessive-compulsive disorder: an updateJoseph Zohar
Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Tel Aviv University, Israel
J Clin Psychiatry 65:18-21. 2004..However, taking into account that OCD is a heterogeneous syndrome, the 5-HT(1D) hypothesis requires further investigation in order to disentangle the role of the 5-HT(1D) receptor in this common and often severe disorder...
